MENU

Ian Pierce

I am a longtime Fool from the States relocated to London. With decades to go before retirement, I'm focused on AIM-listed small caps and growth shares of all stripes. My favourite companies are those that are looking to shake up stodgy industries with fresh ideas. After living and working in China for several years, I also have a soft spot for companies looking to take advantage of the long term potential to be found selling to a 100 million strong middle class.

2 high risk growth stocks I’d avoid right now

Why these highly-priced growth shares are looking dangerously overvalued. More »

2 family-owned businesses to retire on

These family-led firms offer growth, dividends and a long-term approach investors should love. More »

2 growth dividend stocks at the top of my buy list

Double-digit earnings growth and dividend yields above 3% have these stocks on my radar. More »

Does Vanguard’s entry into the UK market mark the end of the line for this top FTSE 100 growth stock?

Shares of this investor favourite are down over 5% this week on news. But is it time to flee or time to buy? More »

Is this FTSE 250 growth stock an unmissable bargain at just 15 times earnings?

This growth stock has outperformed the FTSE 250 (INDEXFTSE: MCX) by over 50% in the past five years, so why is it so cheap?... More »

2 top FTSE 250 growth stocks I’d buy on the dip

Why I'd love to own these FTSE 250 (INDEXFTSE: MCX) stars that have trounced the index over the past five years. More »

Is this new IPO the growth stock to retire on?

This new IPO is already up over 30% in value. But is it one to buy for the long term? More »

2 supercharged income stocks trading at bargain prices

P/E ratios under 15 and yields over 4.5% have me intrigued by these stocks. More »

2 cracking growth stocks I’d buy for the long term

Industry tailwinds and cutting-edge products have set these small-caps up for bumper long-term growth. More »

Yields over 5%. P/Es under 10. Are these 2 stocks the bargains of the century?

Will these turnaround stories prove value investors' best friends or worst nightmares? More »

This top stock is on its way to 5 straight years of double-digit earnings growth

Organic growth and a big new acquisition mean this company's stellar performance is set to continue. More »

2 under-the-radar growth stocks with huge upside potential

Disappointed by low growth large-caps? These two unknown stocks generating fantastic shareholder returns may be the cure. More »

Is this the most recession-proof share you can buy?

Is this big new IPO your best bet for steady, non-cyclical growth? More »

2 FTSE 100 giants primed to outperform the index in the long term

These two high quality stocks can continue to trounce the cyclical FTSE 100 (INDEXFTSE: UKX). More »

One company with 60%+ operating margins I’d buy right now

This stock is on my radar due to double-digit growth, sky-high margins and huge potential for big shareholder returns. More »

Why this top dividend stock also has huge growth potential

This non-cyclical growth stock's large and growing dividends have me very interested. More »

Can this former FTSE 250 stinker continue its 130%+ rally?

Will interim results continue the fantastic rally for this formerly hated stock? More »

This growth share’s maiden 4.7% dividend illustrates huge income potential

Why this initial 4.7% dividend yield could be just the beginning for this top growth share. More »

Is Mediclinic International plc a screaming buy as shares surge 20% higher?

Regulatory rollbacks send shares of Mediclinic International plc (LON: MDC) soaring 20%. Time to buy? More »

Two top dividend stocks trading at bargain valuations

These stellar stocks offer trade at under 12 time earnings and offer 3%-plus dividend yields. More »